Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Urges Alternative Heart Attack Testing Methods After Quidel Cardiac Panel Recall Delays in identifying a heart attack using the recalled Quidel cardiac panels could result in long-term, and even deadly, heart damage, the FDA warns. July 20, 2023 Katherine McDaniel Add Your Comments Federal health officials are urging hospitals and emergency departments to use alternative heart attack testing methods, following a recall issued this week for nearly 8,000 Quidel cardiac panels that may provide inaccurate results. The U.S. Food and Drug Administration (FDA) issued a letter to healthcare providers on July 19, indicating that recalled Quidel triage cardiac panels should no longer be used. However, the agency warns that healthcare providers may have difficulty finding unaffected heart attack test kits following the recall, and recommends alternative testing options be explored. Recalled Quidel blood tests may lead to flawed results, and potentially cause a heart attack misdiagnosis or incorrect treatment recommendations, according to the FDA. This could result in patients suffering heart damage and even death which could have been avoided if their heart attacks were correctly and rapidly diagnosed. The agency indicates that all remaining, non-recalled Quidel test kits will be prioritized for facilities who are unable to use another test, or do not have access to another testing facility. While adequate quantities of alternative tests are available from other suppliers, officials note some facilities may not have these alternative options available to them, or could face delays in receiving the new tests. Quidel Triage Cardiac Panel Recall Quidel triage blood tests are commonly used in the emergency room, to quickly identify elevated enzymes and proteins released in an individual’s blood during a cardiac event. Healthcare professionals rely on the cardiac blood panels to rapidly and accurately detect elevated blood markers, in order to diagnose a heart attack or other serious cardiac injury immediately, so that they may provide the proper life-saving treatment in a timely manner. Following dozens of reports involving the tests failing to detect elevated levels of proteins and enzymes that are present in the blood when a heart attack occurs, the manufacturer issued a Quidel Triage Cardiac Panel recall on May 25. The recall impacts approximately 7,799 Quidel Triage Cardiac Panel, Quidel Triage Cardiac Panel: Troponin I, and Quidel Triage Cardiac Panel: CK-MB and Troponin I blood tests with product codes 97000HS, 97021HS, and 97022HS. The tests were distributed in the U.S. from November 1, 2022 until May 25, 2023. The FDA classified the action as a Class I recall, the most serious of its kind, and indicated that consumers face an increased risk of suffering serious injuries or death with continued use. In the recall notice, officials warned that inaccurate troponin levels detected in the blood can cause a misdiagnosis or failure to diagnose a heart attack, and may lead to incorrect or delayed treatment, which can result in serious injury or death. Patients who are suffering from a silent heart attack, or other heart conditions which do not present noticeable symptoms and require accurate blood test results to diagnose and treat, are especially as risk of sustaining serious injuries to the heart. Heart attacks, or myocardial infarctions, require early detection and intervention in order to effectively protect the heart from damage, and failure to immediately diagnose and treat the condition may result in potentially life-threatening injuries or death. While no injuries or deaths have been reported in relation to the recall, QuidelOrtho has become aware of at least 41 incidents involving the defective devices producing false or negative readings. Officials have indicated there are currently limited quantities of unaffected Quidel cardiac panels available, and the manufacturer, QuidelOrtho, will be prioritizing distribution of them to customers who do not have access to an alternative testing method. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA recommends healthcare professionals immediately discontinue use of the cardiac panels and use an alternative testing method, or direct their patient to another testing site that can provide accurate blood test results. If a customer is unable to use a different testing method or find an alternative facility to refer their patients for accurate testing, and must use the devices, they are urged to follow the original guidance issued with the May 25 recall notice. For more information, or to submit additional questions or concerns, customers are being asked to contact QuidelOrtho by phone at 858-552-1100, or their local QuidelOrtho Technical Solutions Center. The FDA encourages consumers and health care professionals to report any adverse reactions or issues experienced while using the medial devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using the online reporting form. Tags: Failure to Diagnosis, Heart Attack, Medical Device Recall, Misdiagnosis More Lawsuit Stories Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” July 3, 2025 Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL July 3, 2025 JAK Inhibitors Could Increase Cancer Risks by as Much as 40%: Study July 3, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: today) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: today) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: yesterday) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: today) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: today) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: yesterday) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)